vs
Side-by-side financial comparison of MEDIFAST INC (MED) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $53.8M, roughly 1.4× SMARTFINANCIAL INC.). Over the past eight quarters, SMARTFINANCIAL INC.'s revenue compounded faster (15.4% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
MED vs SMBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $75.1M | $53.8M |
| Net Profit | — | $13.7M |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | — |
| Net Margin | — | 25.4% |
| Revenue YoY | -36.9% | — |
| Net Profit YoY | — | 21.6% |
| EPS (diluted) | $-1.64 | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $53.8M | ||
| Q4 25 | $75.1M | $53.3M | ||
| Q3 25 | $89.4M | $51.1M | ||
| Q2 25 | $105.6M | $49.2M | ||
| Q1 25 | $115.7M | $46.8M | ||
| Q4 24 | $119.0M | $46.8M | ||
| Q3 24 | $140.2M | $44.2M | ||
| Q2 24 | $168.6M | $40.4M |
| Q1 26 | — | $13.7M | ||
| Q4 25 | — | $13.7M | ||
| Q3 25 | $-2.3M | $13.7M | ||
| Q2 25 | $2.5M | $11.7M | ||
| Q1 25 | $-772.0K | $11.3M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $1.1M | $9.1M | ||
| Q2 24 | $-8.2M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | -10.4% | 31.3% | ||
| Q3 25 | -4.6% | 33.2% | ||
| Q2 25 | -1.0% | 29.0% | ||
| Q1 25 | -1.1% | 29.0% | ||
| Q4 24 | 0.6% | 26.5% | ||
| Q3 24 | 1.5% | 24.3% | ||
| Q2 24 | -4.7% | 25.6% |
| Q1 26 | — | 25.4% | ||
| Q4 25 | — | 25.7% | ||
| Q3 25 | -2.5% | 26.8% | ||
| Q2 25 | 2.3% | 23.8% | ||
| Q1 25 | -0.7% | 24.0% | ||
| Q4 24 | — | 20.6% | ||
| Q3 24 | 0.8% | 20.7% | ||
| Q2 24 | -4.8% | 19.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | $-1.64 | $0.81 | ||
| Q3 25 | $-0.21 | $0.81 | ||
| Q2 25 | $0.22 | $0.69 | ||
| Q1 25 | $-0.07 | $0.67 | ||
| Q4 24 | $0.08 | $0.57 | ||
| Q3 24 | $0.10 | $0.54 | ||
| Q2 24 | $-0.75 | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $346.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $198.9M | $562.2M |
| Total Assets | $248.0M | $5.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $346.1M | ||
| Q4 25 | $167.3M | $464.4M | ||
| Q3 25 | $173.5M | $557.1M | ||
| Q2 25 | $162.7M | $365.1M | ||
| Q1 25 | $164.6M | $423.0M | ||
| Q4 24 | $162.3M | $387.6M | ||
| Q3 24 | $170.0M | $192.9M | ||
| Q2 24 | $163.5M | $342.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | $562.2M | ||
| Q4 25 | $198.9M | $552.4M | ||
| Q3 25 | $214.7M | $538.4M | ||
| Q2 25 | $216.0M | $519.0M | ||
| Q1 25 | $211.0M | $505.8M | ||
| Q4 24 | $210.1M | $491.3M | ||
| Q3 24 | $207.3M | $489.0M | ||
| Q2 24 | $205.3M | $472.5M |
| Q1 26 | — | $5.9B | ||
| Q4 25 | $248.0M | $5.9B | ||
| Q3 25 | $268.2M | $5.8B | ||
| Q2 25 | $269.3M | $5.5B | ||
| Q1 25 | $280.0M | $5.4B | ||
| Q4 24 | $284.2M | $5.3B | ||
| Q3 24 | $291.2M | $4.9B | ||
| Q2 24 | $293.5M | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | — |
| Free Cash FlowOCF − Capex | $-6.6M | — |
| FCF MarginFCF / Revenue | -8.8% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-5.3M | $61.7M | ||
| Q3 25 | $12.1M | $16.9M | ||
| Q2 25 | $-3.4M | $14.0M | ||
| Q1 25 | $3.4M | $14.3M | ||
| Q4 24 | $-4.9M | $52.7M | ||
| Q3 24 | $9.1M | $12.4M | ||
| Q2 24 | $13.1M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.6M | $59.3M | ||
| Q3 25 | $10.8M | $16.6M | ||
| Q2 25 | $-4.8M | $13.2M | ||
| Q1 25 | $1.9M | $13.4M | ||
| Q4 24 | $-7.2M | $46.3M | ||
| Q3 24 | $7.7M | $11.3M | ||
| Q2 24 | $11.1M | $15.4M |
| Q1 26 | — | — | ||
| Q4 25 | -8.8% | 111.3% | ||
| Q3 25 | 12.0% | 32.4% | ||
| Q2 25 | -4.5% | 26.9% | ||
| Q1 25 | 1.6% | 28.5% | ||
| Q4 24 | -6.1% | 98.9% | ||
| Q3 24 | 5.5% | 25.7% | ||
| Q2 24 | 6.6% | 38.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 4.5% | ||
| Q3 25 | 1.5% | 0.6% | ||
| Q2 25 | 1.3% | 1.6% | ||
| Q1 25 | 1.3% | 2.0% | ||
| Q4 24 | 1.9% | 13.7% | ||
| Q3 24 | 1.0% | 2.4% | ||
| Q2 24 | 1.1% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.50× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | -1.36× | 1.20× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | — | 5.47× | ||
| Q3 24 | 8.04× | 1.36× | ||
| Q2 24 | — | 2.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |